Admin Posted April 13, 2021 Share Posted April 13, 2021 Over 6.8 million Americans have received the Johnson & Johnson COVID-19 vaccine, which is now facing renewed scrutiny after six of those recipients developed a rare, severe type of blood clot that has caused the FDA and Centers for Disease Control and Prevention (CDC) to recommend a pause in the rollout. View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.